MA46291A - Agents anti-cancéreux et leur préparation - Google Patents
Agents anti-cancéreux et leur préparationInfo
- Publication number
- MA46291A MA46291A MA046291A MA46291A MA46291A MA 46291 A MA46291 A MA 46291A MA 046291 A MA046291 A MA 046291A MA 46291 A MA46291 A MA 46291A MA 46291 A MA46291 A MA 46291A
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- cancer agents
- cancer
- agents
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662398783P | 2016-09-23 | 2016-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46291A true MA46291A (fr) | 2019-07-31 |
Family
ID=61690726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046291A MA46291A (fr) | 2016-09-23 | 2017-09-22 | Agents anti-cancéreux et leur préparation |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10858371B2 (enExample) |
| EP (1) | EP3515492B1 (enExample) |
| JP (1) | JP7111722B2 (enExample) |
| KR (1) | KR102646702B1 (enExample) |
| CN (1) | CN109862916A (enExample) |
| AU (1) | AU2017331260B2 (enExample) |
| BR (1) | BR112019005885A2 (enExample) |
| CA (1) | CA3037883A1 (enExample) |
| DK (1) | DK3515492T3 (enExample) |
| IL (1) | IL265521B2 (enExample) |
| MA (1) | MA46291A (enExample) |
| MX (1) | MX394670B (enExample) |
| RU (1) | RU2019111768A (enExample) |
| WO (1) | WO2018057897A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109862916A (zh) | 2016-09-23 | 2019-06-07 | 普渡研究基金会 | 抗癌剂及其制备 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR901464A (fr) | 1943-01-23 | 1945-07-27 | Boehringer & Soehne Gmbh | Procédé d'obtention de vanilline |
| US7825267B2 (en) | 2006-09-08 | 2010-11-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Synthesis of FR901464 and analogs with antitumor activity |
| WO2009031999A1 (en) | 2007-09-07 | 2009-03-12 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Fr901464 and analogs with antitumor activity and method for their preparation |
| CN101417934B (zh) * | 2007-10-24 | 2012-04-18 | 国鼎生物科技股份有限公司 | 分离自牛樟芝萃取物的化合物 |
| KR20160125535A (ko) | 2008-03-18 | 2016-10-31 | 제넨테크, 인크. | 항-ｈｅｒ２ 항체-약물 접합체와 화학요법제의 병용물, 및 사용 방법 |
| WO2009155606A1 (en) | 2008-06-21 | 2009-12-23 | St. Jude Children's Research Hospital | Anticancer compounds and methods of making and using same |
| US20150025017A1 (en) | 2012-02-28 | 2015-01-22 | Fred Hutchinson Cancer Research Center | Compositions and methods for treating cancer |
| CA2890569C (en) | 2012-11-05 | 2019-03-05 | Pfizer Inc. | Spliceostatin analogs |
| WO2014100367A1 (en) | 2012-12-21 | 2014-06-26 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Synthesis of fr901464 and analogs with antitumor activity |
| US20140274979A1 (en) | 2013-03-13 | 2014-09-18 | Golden Biotechnology Corporation | Method for the treatment of fatty liver disease |
| CA2955059A1 (en) | 2013-07-15 | 2015-01-22 | Bettina PRONETH | Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death |
| KR102092569B1 (ko) * | 2013-09-17 | 2020-03-25 | 엘지디스플레이 주식회사 | 터치 스크린 일체형 디스플레이 장치와 이의 구동 방법 |
| MX375896B (es) * | 2013-11-19 | 2025-03-07 | Purdue Research Foundation | Agentes anticancerosos y sus preparaciones. |
| AU2017277786A1 (en) * | 2016-06-08 | 2019-01-03 | William Marsh Rice University | Derivatives of Thailanstatin A, methods of treatment and methods of synthesis thereof |
| CN109862916A (zh) | 2016-09-23 | 2019-06-07 | 普渡研究基金会 | 抗癌剂及其制备 |
-
2017
- 2017-09-22 CN CN201780065546.7A patent/CN109862916A/zh active Pending
- 2017-09-22 DK DK17853991.2T patent/DK3515492T3/da active
- 2017-09-22 JP JP2019537750A patent/JP7111722B2/ja active Active
- 2017-09-22 WO PCT/US2017/052967 patent/WO2018057897A1/en not_active Ceased
- 2017-09-22 IL IL265521A patent/IL265521B2/en unknown
- 2017-09-22 AU AU2017331260A patent/AU2017331260B2/en active Active
- 2017-09-22 MA MA046291A patent/MA46291A/fr unknown
- 2017-09-22 MX MX2019003368A patent/MX394670B/es unknown
- 2017-09-22 CA CA3037883A patent/CA3037883A1/en active Pending
- 2017-09-22 EP EP17853991.2A patent/EP3515492B1/en active Active
- 2017-09-22 BR BR112019005885-0A patent/BR112019005885A2/pt unknown
- 2017-09-22 KR KR1020197011144A patent/KR102646702B1/ko active Active
- 2017-09-22 RU RU2019111768A patent/RU2019111768A/ru unknown
- 2017-09-22 US US16/335,378 patent/US10858371B2/en active Active
-
2020
- 2020-11-09 US US17/092,829 patent/US11851441B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3037883A1 (en) | 2018-03-29 |
| CN109862916A (zh) | 2019-06-07 |
| IL265521B2 (en) | 2024-09-01 |
| MX394670B (es) | 2025-03-11 |
| JP7111722B2 (ja) | 2022-08-02 |
| JP2019529563A (ja) | 2019-10-17 |
| EP3515492A4 (en) | 2020-04-08 |
| KR20190077340A (ko) | 2019-07-03 |
| BR112019005885A2 (pt) | 2020-06-02 |
| RU2019111768A3 (enExample) | 2020-11-24 |
| WO2018057897A1 (en) | 2018-03-29 |
| IL265521A (en) | 2019-05-30 |
| US11851441B2 (en) | 2023-12-26 |
| AU2017331260B2 (en) | 2024-11-07 |
| IL265521B1 (en) | 2024-05-01 |
| RU2019111768A (ru) | 2020-10-23 |
| AU2017331260A1 (en) | 2019-05-16 |
| US20210395265A1 (en) | 2021-12-23 |
| DK3515492T3 (da) | 2023-08-28 |
| EP3515492A1 (en) | 2019-07-31 |
| MX2019003368A (es) | 2019-09-16 |
| US20190218228A1 (en) | 2019-07-18 |
| EP3515492B1 (en) | 2023-07-26 |
| KR102646702B1 (ko) | 2024-03-11 |
| US10858371B2 (en) | 2020-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2021006I2 (el) | Αντιγριπικο πολυκυκλικο παραγωγο πυριδονης και προφαρμακο αυτου | |
| EP3384077A4 (en) | FUNCTIONALIZED SURFACES AND MANUFACTURE THEREOF | |
| CL2018000813A1 (es) | Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso. | |
| IL262751A (en) | Pharmaceutical compositions with enhanced permeation | |
| MA46525A (fr) | Anticorps anti-lag-3 et compositions | |
| MA44659A (fr) | Anticorps anti-tim-3 et compositions | |
| EP3513809A4 (en) | MEDICAL COMPOSITION | |
| PL3423087T3 (pl) | Skojarzona terapia przeciwnowotworowa | |
| DK3411393T3 (da) | Administration af manipulerede t-celler til behandling af cancere i centralnervesystemet | |
| MA50541A (fr) | Formulations pharmaceutiques | |
| MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
| EP3310376A4 (en) | MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF | |
| EP3636246A4 (en) | COSMETIC PREPARATION WITH WATER-IN-OIL EMULSION | |
| DK3380139T3 (da) | Medikamentadministrationsanordning | |
| MA42303A (fr) | Formulations pharmaceutiques | |
| EP3316685A4 (en) | Lyophilized Pharmaceutical Compositions | |
| DK3380146T3 (da) | Medikamentadministrationsanordning | |
| MA44987A (fr) | Formulations de médicaments améliorées | |
| EP3359962A4 (en) | BLOOD PREPARATION AND PROFILING | |
| DK3275452T3 (da) | Farmaceutisk sammensætning med silibinin | |
| EP3353159A4 (en) | Modified cytotoxins and their therapeutic use | |
| DK3349825T3 (da) | Lægemiddeladministrationsanordning | |
| MA40524A (fr) | Dérivés d'adrénomédulline stabilisés et leur utilisation | |
| DK3349827T3 (da) | Lægemiddeladministrationsanordning | |
| DK3313370T3 (da) | Oftalmologisk farmaceutisk sammensætning |